HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

N- (4- ((6,7- dimethoxy- 4- quinolyl)oxy)- 2- methoxyphenyl)- N'- (1- (1,3- thiazole- 2- yl)ethyl)urea

a c-fms tyrosine kinase inhibitor; structure in first source
Also Known As:
Ki 20227; Ki-20227; Ki20227
Networked: 14 relevant articles (1 outcomes, 3 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Kubo, Kazuo: 3 articles (03/2008 - 11/2006)
2. Murooka, Hideko: 3 articles (03/2008 - 11/2006)
3. Ohno, Hiroaki: 3 articles (03/2008 - 11/2006)
4. Jiang, Cheng: 2 articles (01/2022 - 01/2020)
5. Chen, Shijia: 2 articles (01/2020 - 01/2020)
6. Du, Xiaoxue: 2 articles (01/2020 - 01/2020)
7. Fang, Marong: 2 articles (01/2020 - 01/2020)
8. Ohzeki, Yumiko: 2 articles (03/2008 - 01/2008)
9. Serizawa, Isao: 2 articles (03/2008 - 01/2008)
10. Takanashi, Hiromi: 2 articles (03/2008 - 01/2008)

Related Diseases

1. Stroke (Strokes)
2. Brain Ischemia (Cerebral Ischemia)
3. Neoplasms (Cancer)
4. Bone Resorption
5. Disease Progression

Related Drugs and Biologics

1. Tyrosine Kinase Inhibitors
2. Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)
3. Collagen Type II (Type II Collagen)
4. Urea (Carbamide)
5. Thiazoles
6. Macrophage Colony-Stimulating Factor
7. Proteins (Proteins, Gene)
8. Inflammasomes
9. Neutralizing Antibodies
10. Caspase 1 (ICE Protease)

Related Therapies and Procedures

1. Oral Administration
2. Ligation